logo

Zealand Pharma A/S (ZEAL)



Trade ZEAL now with
  Date
  Headline
9/30/2022 6:29:20 AM Zealand Pharma Announces Positive Results From Phase 3 Trial Of Glepaglutide In Patients With Short Bowel Syndrome
5/17/2022 6:17:25 AM MannKind Enters Deal To Acquire V-Go Insulin Delivery Device From Zealand Pharma
1/20/2022 7:37:46 AM Zealand Pharma Completes Enrollment In EASE-SBS 1 Phase 3 Trial Assessing Glepaglutide In Short Bowel Syndrome
6/24/2021 7:16:22 AM Zealand Pharma Reports U.S. Commercial Availability Of ZEGALOGUE Injection In Both Auto-injector And Prefilled Syringe